← All trials
NCT05968430
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 14, 2023
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Aug 1, 2023
- Last posted
- Dec 22, 2023
- Enrollment
- 900
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mineralys Therapeutics Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.